Brain-computer interfaces are slowly edging into the mainstream.
Aftera stringof scientific breakthroughs, neurotech companies are starting to commercialize their research.
Among them isBlackrock Neurotech, which focuses on restoring functionsthat have been impaired by disabilities or accidents.
The company isbest-knownfor developing a neural implant that enabled a paralyzed man tocontrol a robotic arm with his mind.
In 2022, the Utah-based firmplans to launch its first commercial rig.
Shortly thereafter, well have a fully implantable wireless version as well with even more capability.
40% off TNW Conference!
The startupsflashy demosand Musks bombastic predictions have attracted hyperbolic headlines, but many neuroscientists are skeptical about the work.
They point to the companysdearth of peer-reviewed papers,lack of innovation, and Muskshistory of overpromising.
Theres a concern with Neuralink saying its going to become a consumer product, says Solzbacher.
We need to have these discussions.
Quite frankly, however, this scenario is not even realistic right now.
And so those in positions of influence need to be careful not to create unnecessary fear.
Musks involvement can nonetheless attract interest and investment in BCIs.
Solzbacher emphasizes the importance of moving step-by-step.
In time, however, implants for able-bodied people may become a reality.
The possibilities are endless.
In the distant future, BCIs could createtransformative gaming experiences, improvethe performance of first respondents orturbocharge surveillance.
We owe that to the world.
No one in the neuroscience field wants to inadvertently hurt the people we want to help the most.
Story byThomas Macaulay
Thomas is the managing editor of TNW.
He leads our coverage of European tech and oversees our talented team of writers.
Away from work, he e(show all)Thomas is the managing editor of TNW.
He leads our coverage of European tech and oversees our talented team of writers.
Away from work, he enjoys playing chess (badly) and the guitar (even worse).
